Proteomic analysis of nuclear extract of human leukaemic cells (HL60) exposed to proteasome inhibitor-MG132

被引:0
|
作者
Qian, Jun-jie [1 ]
Sun, Guo-jing [1 ]
Meng, Xiang-bing [1 ]
Song, Yi [1 ]
Mei, Zhu-zhong [1 ]
Bin Liu [1 ]
Dong, Yan [1 ]
Sun, Zhi-xian [1 ]
机构
[1] Beijing Inst Radiat Med, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:S330 / S330
页数:1
相关论文
共 50 条
  • [21] Proteasome inhibitor MG132 enhances the antigrowth and antimetastasis effects of radiation in human nonsmall cell lung cancer cells
    Liu, Jing
    Shen, Wenhao
    Tang, Yiting
    Zhou, Jundong
    Li, Ming
    Zhu, Wei
    Yang, Hongying
    Wu, Jinchang
    Zhang, Shuyu
    Cao, Jianping
    TUMOR BIOLOGY, 2014, 35 (08) : 7531 - 7539
  • [22] Induction of apoptosis in human osteosarcoma Saos-2 cells by the proteasome inhibitor MG132 and the protective effect of pRb
    Lauricella, M
    D'Anneo, A
    Giuliano, M
    Calvaruso, G
    Emanuele, S
    Vento, R
    Tesoriere, G
    CELL DEATH AND DIFFERENTIATION, 2003, 10 (08): : 930 - 932
  • [23] Induction of apoptosis in human osteosarcoma Saos-2 cells by the proteasome inhibitor MG132 and the protective effect of pRb
    M Lauricella
    A D'Anneo
    M Giuliano
    G Calvaruso
    S Emanuele
    R Vento
    G Tesoriere
    Cell Death & Differentiation, 2003, 10 : 930 - 932
  • [24] Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis
    Hougardy, BMT
    Maduro, JH
    van der Zee, AGJ
    de Groot, DJA
    van den Heuvel, FAJ
    de Vries, EGE
    de Jong, S
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (08) : 1892 - 1900
  • [25] Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells
    Cusimano, Antonella
    Azzolina, Antonina
    Iovanna, Juan L.
    Bachvarov, Dimcho
    McCubrey, James A.
    D'Alessandro, Natale
    Montalto, Giuseppe
    Cervello, Melchiorre
    CELL CYCLE, 2010, 9 (07) : 1399 - 1410
  • [26] Effect of MG132, a proteasome inhibitor, on the expression of growth related oncogene protein-α in human umbilical vein endothelial cells
    Shibata, T
    Imaizumi, T
    Matsumiya, T
    Tamo, W
    Hatakeyama, M
    Yoshida, H
    Munakata, H
    Fukuda, I
    Satoh, K
    CYTOKINE, 2003, 24 (03) : 67 - 73
  • [27] The proteasome inhibitor MG132 induces nuclear translocation of erythroid transcription factor Nrf2 and cyclooxygenase-2 expression in human vascular endothelial cells
    Sahni, Sanjeev K.
    Rydkina, Elena
    Sahni, Abha
    THROMBOSIS RESEARCH, 2008, 122 (06) : 820 - 825
  • [28] Synergism between arsenite and proteasome inhibitor MG132 over cell death in myeloid leukaemic cells U937 and the induction of low levels of intracellular superoxide anion
    Lombardo, Tomas
    Cavaliere, Victoria
    Costantino, Susana N.
    Kornblihtt, Laura
    Alvarez, Elida M.
    Blanco, Guillermo A.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2012, 258 (03) : 351 - 366
  • [29] Proteasome inhibitor MG132 enhances TRAIL-induced apoptosis and inhibits invasion of human osteosarcoma OS732 cells
    Li, Xiucheng
    Huang, Tao
    Jiang, Guangjian
    Gong, Weihua
    Qian, Hao
    Zou, Chunping
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 439 (02) : 179 - 186
  • [30] Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-induced apoptosis of human esophageal squamous cell carcinoma cells
    Dang, Lifeng
    Wen, Fengbiao
    Yang, Yang
    Liu, Donglei
    Wu, Kai
    Qi, Yu
    Li, Xiangnan
    Zhao, Jia
    Zhu, Dengyan
    Zhang, Chunyang
    Zhao, Song
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 33 (05) : 1083 - 1088